RxDoctor Payments Data

Gregory D Angelo, MD

Orthopaedic Surgery · Lexington, KYNPI 1144280645

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (54.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 64.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $8,003 and has fallen 60.1% since, to $3,190 in 2025.

$25,354in general payments, 2019–2025

Across 65 payments — averaging $390.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$16K
  • Medical Device Business Services, Inc.$4K
  • Steris Corporation$2K
  • Stryker$895
  • Depuy Synthes Products, Inc.$781
  • Smith+Nephew$451
  • plus $938 from 14 others

What the payments were for

  • Royalty or licence$13,87555%
  • Consulting fees$3,60014%
  • Speaking & faculty fees$1,7737%
  • Travel & lodging$4,37417%
  • Food & beverage$1,7327%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,354 in reported general payments places this provider in the 80th percentile of 322 orthopaedic surgery providers in Kentucky.

See all orthopaedic surgery providers in Kentucky →

Medicare billing

Part B allowed, 2024
$164,330
Medicare patients
291
Services billed
1,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl150$727
Tramadol Hcl232$616
Meloxicam220$486
Ondansetron Hcl146$364
Cefadroxil101$268
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$164
Celecoxib12$152
Cephalexin47$50
Doxycycline Hyclate29$42
Clindamycin Hcl18$11

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lexington

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →